United States

Showing 211-220 of 325 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare	Nemours Children's Clinic	Jessica Pierce	Improving Lives	01-May-2023 to 30-April-2026	$628,819.87
Anti-Serpin B13 Hu-mAb Lead Candidate Developability Assessment	Mosaic Biosciences, Inc.	Malavi Madireddi	Cures	01-June-2025 to 22-July-2026	$293,674.00
Evaluating the Impact of High-Risk HLA-DR Serotypes on the Cellular Neighborhood of the Pancreatic Islets: Towards Early Identification of T1D Disease Risk and Prevention	Missouri University of Science and Technology	Gina Yosten	Cures	01-October-2025 to 30-September-2028	$740,097.60
Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes	Minutia	Katy Digovich	Cures	01-November-2022 to 30-November-2025	$1,198,600.00
Market Analysis of Devices Utilized By Patients With T1D & Eligibility For Future T1D Cell and Gene Therapies	Milliman	Rebecca Smith	Cures	01-January-2025 to 31-October-2025	$380,000.00
Market Analysis of Insulin Products Utilized by Patients With T1D & Pervasiveness of Insulin Caps	Milliman	Rebecca Smith	Transportfolio	01-January-2025 to 31-December-2025	$590,000.00
Multicolor cellular immunoimaging of response to transplanted islet cells	Michigan State University	Bryan Smith	Cures	01-June-2023 to 31-May-2026	$750,000.00
Autoimmune stem-like T cells in type 1 diabetes	Memorial Sloan-Kettering Cancer Center	Andrea Schietinger	Cures	01-September-2023 to 31-August-2026	$750,000.00
Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Patients	Mayo Clinic	Adrian Vella	Improving Lives	01-October-2019 to 31-March-2025	$365,991.93
Assessment of Beta Cell Small Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes	Mayo Clinic	Naureen Javeed	Cures	01-September-2022 to 31-August-2025	$400,000.00